Plasmapp (405000), a bio-plasma deep tech company, participated in the Western Veterinary Conference, the largest animal hospital exhibition in the United States held in Las Vegas from February 18th to 21st, with the largest TOP 2 distribution company in North America Covetrus and Patterson. They have successfully sold Plasmap's low-temperature sterilizer (brand: STERLINK) announced on the 21st.

Covetrus is a global company that continues to be ranked first in terms of sales channels and sales volume in the U.S. and global veterinary hospital markets, and began cooperation with Plasmapp last year to enter the U.S. veterinary hospital market. Plasmapp has been developing a new sterilizer lineup product (model: STERLINK U510) that maximizes usability and economics since last year, and Covetrus selected the new product as a branded product (Covetrus Branded Product) at the WVC exhibition in February of this year and officially launched it. We started selling together.

Patterson is the second-largest distribution company in sales in the U.S. animal hospital market. At this exhibition, we carried out differentiated marketing for Plasmapp's existing premium products and are considering additional introduction of a new sterilizer lineup.

Youbong Lim, CEO of Plasmapp, said, “By working with major global distributors, we have derived accurate market requirements and thoroughly prepared to develop and launch a new sterilizer lineup tailored to them. We have recently achieved significant results with the launch of new products in various domestic and international markets. “We will do our best to maximize both sales growth and profitability this year.”

Meanwhile, Plasmapp officially launched its universal lineup of medical low-temperature plasma sterilizers at the Korean Ophthalmological Association conference held at the Swiss Grand Hotel in Seoul on February 18 and began full-scale sales in the domestic ophthalmology market. Plasmapp plans to quickly grow the market by participating in various domestic medical exhibitions in the future based on the sales channel secured at the Middle East's largest medical exhibition (Arab Health).